UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results

International journal of radiation oncology, biology, physics, 2013-03, Vol.85 (3), p.672-678

2013

Volltextzugriff (PDF)

Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience

Journal of radiation research, 2019-07, Vol.60 (4), p.501-508

2019

Volltextzugriff (PDF)

A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience

BMC cancer, 2019-03, Vol.19 (1), p.221-221, Article 221

2019

Volltextzugriff (PDF)

Treating the Chameleon: Radiotherapy in the management of Renal Cell Cancer

Clinical and translational radiation oncology, 2019-05, Vol.16, p.7-14

2019

Volltextzugriff (PDF)

Real-world dosimetric comparison between CyberKnife SBRT and HDR brachytherapy for the treatment of prostate cancer

Brachytherapy, 2021-01, Vol.20 (1), p.44-49

2021

Volltextzugriff (PDF)

Iridium-Knife: Another knife in radiation oncology

Brachytherapy, 2017-07, Vol.16 (4), p.884-892

2017

Volltextzugriff (PDF)

Image‐guided interstitial high‐dose‐rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation

Head & neck, 2017-04, Vol.39 (4), p.E61-E68

2017

Volltextzugriff (PDF)

Matched-pair dosimetric comparison of cardiac radiation exposure between deep-inspiration breath-hold whole-breast radiation therapy with Active Breathing Coordinator and interstitial multicatheter high-dose-rate brachytherapy as accelerated partial breast irradiation in adjuvant treatment of left-sided breast cancer after breast-conserving surgery

Strahlentherapie und Onkologie, 2021-04, Vol.197 (4), p.308-316

2021

Volltextzugriff (PDF)

High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up

Frontiers in oncology, 2021-12, Vol.11, p.770959-770959

2021

Volltextzugriff (PDF)

Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

EJNMMI research, 2021-07, Vol.11 (1), p.1-11, Article 61

2021

Volltextzugriff (PDF)

Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies

Cancers, 2022-05, Vol.14 (10), p.2391

2022

Volltextzugriff (PDF)

Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer

Cancers, 2021-11, Vol.13 (22), p.5748

2021

Volltextzugriff (PDF)

Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer

Journal of radiation research, 2021-05, Vol.62 (3), p.465-472

2021

Volltextzugriff (PDF)

Radioimmunotherapy: future prospects from the perspective of brachytherapy

Journal of contemporary brachytherapy, 2021-01, Vol.13 (4), p.458-467

2021

Volltextzugriff (PDF)

Outcome of 177Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer

Cancers, 2021-08, Vol.13 (16), p.4193

2021

Volltextzugriff (PDF)

Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer

Cancers, 2023-09, Vol.15 (18), p.4605

2023

Volltextzugriff (PDF)

Die Rolle der Radiotherapie bei der Behandlung des Nierenzellkarzinoms

Uro-news, 2022-05, Vol.26 (5), p.24-31

2022

Volltextzugriff (PDF)

Baseline [ 68 Ga]Ga-PSMA-11 PET/CT before [ 177 Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions

Cancers, 2023-01, Vol.15 (2), p.473

2023

Volltextzugriff (PDF)

Impact of [ 177 Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [ 68 Ga]Ga-PSMA-11-PET/CT

Cancers, 2023-07, Vol.15 (15), p.3878

2023

Volltextzugriff (PDF)

Salvage Radioligand Therapy with Repeated Cycles of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement

Cancers, 2021-08, Vol.13 (16), p.4017

2021

Volltextzugriff (PDF)

Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study

Brachytherapy, 2018-03, Vol.17 (2), p.368-376

2018

Volltextzugriff (PDF)

Safety and Efficacy of 177Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing 223Radium-Dichloride

Cancers, 2022-01, Vol.14 (3), p.557

2022

Volltextzugriff (PDF)

Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction

Journal of contemporary brachytherapy, 2019-01, Vol.11 (1), p.1-7

2019

Volltextzugriff (PDF)

Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme

Journal of contemporary brachytherapy, 2019-06, Vol.11 (3), p.215-220

2019

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(87)
Japanisch
(15)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(67)
Science & Technology
(67)
Oncology
(62)
Radiology, Nuclear Medicine & Medical Imaging
(44)
Humans
(34)
Radiation Therapy
(30)
Male
(26)
Aged
(24)
Female
(22)
Middle Aged
(22)
Adult
(21)
Brachytherapy
(18)
Prostate Cancer
(17)
Tumors
(17)
Patients
(16)
Radiotherapy
(16)
Aged, 80 And Over
(15)
Metastasis
(15)
Toxicity
(15)
Cancer Therapies
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results

Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience

A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience

Treating the Chameleon: Radiotherapy in the management of Renal Cell Cancer

Real-world dosimetric comparison between CyberKnife SBRT and HDR brachytherapy for the treatment of prostate cancer

Iridium-Knife: Another knife in radiation oncology

Image‐guided interstitial high‐dose‐rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation

High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up

Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies

Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer

Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer

Radioimmunotherapy: future prospects from the perspective of brachytherapy

Outcome of 177Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer

Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer

Die Rolle der Radiotherapie bei der Behandlung des Nierenzellkarzinoms

Baseline [ 68 Ga]Ga-PSMA-11 PET/CT before [ 177 Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions

Impact of [ 177 Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [ 68 Ga]Ga-PSMA-11-PET/CT

Salvage Radioligand Therapy with Repeated Cycles of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement

Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study

Safety and Efficacy of 177Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing 223Radium-Dichloride

Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists

Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction

Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme

Suchergebnisse filtern